Xeraya Capital
Xeraya Capital is a private equity and venture capital firm.
Business Model:
Revenue: $3.1M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Xeraya Capital Information
Geographic Data
Address: 199 Jalan Tun Razak
City: Kuala Lumpur
State: selangor
Zip: 50400
Country: MY
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
8,837,933Website Global Rank
255Website Monthly Traffic
Twitter Followers
Description
Xeraya Capital is a private equity and venture capital firm that focuses on investments in life science companies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2018 | Liquidia Technologies | Series D | 25.5M |
| 1/2020 | P2 Science | Series C | 0 |
| 10/2014 | PrIME Biologics | Venture Round | 12.6M |
| 5/2020 | Rapid Micro Biosystems | Private Equity Round | 0 |
| 6/2019 | Acutus Medical | Series D | 0 |
| 2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
| 8/2016 | ViewRay | Post-IPO Equity | 0 |
| 5/2018 | Rapid Micro Biosystems | Private Equity Round | 60M |
| 11/2020 | Imago BioSciences | Series C | 80M |
| 10/2015 | Boston Neurosciences Inc | Series A | 0 |
| 5/2010 | Gevo | Series D | 0 |
| 7/2015 | ViewRay | Post-IPO Equity | 0 |
| 3/2014 | invendo medical | Venture Round | 0 |
| 11/2020 | Congenica | Series C | 50M |
| 12/2021 | Viron | Series B | 50M |
| 6/2019 | Viron | Series A | 25M |
| 8/2016 | Iconic Therapeutics | Series C | 10M |
| 11/2020 | InterVenn | Series B | 0 |
| 12/2021 | OncoMyx Therapeutics | Series B | 0 |
| 9/2016 | Chrono Therapeutics | Series B | 47.6M |
| 5/2020 | Greenlight Biosciences | Venture Round | 0 |
| 2/2020 | Aria CV | Series B | 0 |
| 3/2017 | P2 Science | Series B | 0 |
| 3/2016 | Acutus Medical | Series C | 75M |
| 2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
| 12/2021 | OncoMyx Therapeutics | Series B | 0 |
| 12/2021 | Viron Inc. | Series B | 0 |
| 11/2020 | Imago BioSciences | Series C | 0 |
| 11/2020 | InterVenn | Series B | 0 |
| 11/2020 | Congenica | Series C | 0 |
| 5/2020 | Rapid Micro Biosystems | Private Equity Round | 0 |
| 5/2020 | Greenlight Biosciences | Venture Round | 0 |
| 2/2020 | Aria CV | Series B | 0 |
| 1/2020 | P2 Science | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
